GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

       
News
Author: News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *